Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 111

1.

Determination of galactosamine impurities in heparin sodium using fluorescent labeling and conventional high-performance liquid chromatography.

Itoh S, Hiruta Y, Hashii N, Fujita N, Natsuga T, Hattori T, Bando A, Sekimoto Y, Miyata K, Namekawa H, Mabuchi K, Sakai T, Shimahashi H, Kawai K, Yoden H, Koyama S, Herr SO, Natsuka S, Yamaguchi T, Kawasaki N.

Biologicals. 2013 Nov;41(6):355-63. doi: 10.1016/j.biologicals.2013.06.002. Epub 2013 Jul 1.

PMID:
23827519
2.

Heparin identification test and purity test for OSCS in heparin sodium and heparin calcium by weak anion-exchange high-performance liquid chromatography.

Hashii N, Kawasaki N, Itoh S, Qin Y, Fujita N, Hattori T, Miyata K, Bando A, Sekimoto Y, Hama T, Kashimura M, Tatsumi M, Mabuchi K, Namekawa H, Sakai T, Hirose M, Dobashi S, Shimahashi H, Koyama S, Herr SO, Kawai K, Yoden H, Yamaguchi T.

Biologicals. 2010 Sep;38(5):539-43. doi: 10.1016/j.biologicals.2010.04.002. Epub 2010 May 7.

PMID:
20452241
3.

Source-induced fragmentation of heparin, heparan, and galactosaminoglycans and application.

Hu P, Fang L, Chess EK.

Anal Chem. 2009 Mar 15;81(6):2332-43. doi: 10.1021/ac802626e.

PMID:
19228018
4.

Development and validation of an ion-exchange chromatography method for heparin and its impurities in heparin products.

Thiangthum S, Vander Heyden Y, Buchberger W, Viaene J, Prutthiwanasan B, Suntornsuk L.

J Sep Sci. 2014 Nov;37(22):3195-204. doi: 10.1002/jssc.201400348. Epub 2014 Sep 25.

PMID:
25146711
5.

Determination of dermatan sulfate and chondroitin sulfate as related substances in heparin by capillary electrophoresis.

Bendazzoli C, Liverani L, Spelta F, Prandi M, Fiori J, Gotti R.

J Pharm Biomed Anal. 2010 Dec 15;53(5):1193-200. doi: 10.1016/j.jpba.2010.07.006. Epub 2010 Jul 31.

PMID:
20674212
6.

Identification of heparin samples that contain impurities or contaminants by chemometric pattern recognition analysis of proton NMR spectral data.

Zang Q, Keire DA, Buhse LF, Wood RD, Mital DP, Haque S, Srinivasan S, Moore CM, Nasr M, Al-Hakim A, Trehy ML, Welsh WJ.

Anal Bioanal Chem. 2011 Aug;401(3):939-55. doi: 10.1007/s00216-011-5155-4. Epub 2011 Jun 17.

PMID:
21678118
7.

Combining (1)H NMR spectroscopy and chemometrics to identify heparin samples that may possess dermatan sulfate (DS) impurities or oversulfated chondroitin sulfate (OSCS) contaminants.

Zang Q, Keire DA, Wood RD, Buhse LF, Moore CM, Nasr M, Al-Hakim A, Trehy ML, Welsh WJ.

J Pharm Biomed Anal. 2011 Apr 5;54(5):1020-9. doi: 10.1016/j.jpba.2010.12.008. Epub 2010 Dec 16.

PMID:
21215547
8.

Synthesis and detection of N-sulfonated oversulfated chondroitin sulfate in marketplace heparin.

Mans DJ, Ye H, Dunn JD, Kolinski RE, Long DS, Phatak NL, Ghasriani H, Buhse LF, Kauffman JF, Keire DA.

Anal Biochem. 2015 Dec 1;490:52-4. doi: 10.1016/j.ab.2015.08.003. Epub 2015 Aug 14.

PMID:
26278168
9.

Determination of Oversulphated Chondroitin Sulphate and Dermatan Sulphate in unfractionated heparin by (1)H-NMR - Collaborative study for quantification and analytical determination of LoD.

McEwen I, Mulloy B, Hellwig E, Kozerski L, Beyer T, Holzgrabe U, Wanko R, Spieser JM, Rodomonte A.

Pharmeuropa Bio. 2008 Dec;2008(1):31-9.

PMID:
19220979
10.

The use of SAX-HPLC-CD as a heparin screening strategy.

Chmielewski AJ, Stanley FE, Stalcup AM.

J Chromatogr B Analyt Technol Biomed Life Sci. 2011 Sep 1;879(25):2619-23. doi: 10.1016/j.jchromb.2011.07.023. Epub 2011 Jul 24.

PMID:
21831728
11.

Analysis of heparin sodium by SAX/HPLC for contaminants and impurities.

Trehy ML, Reepmeyer JC, Kolinski RE, Westenberger BJ, Buhse LF.

J Pharm Biomed Anal. 2009 Apr 5;49(3):670-3. doi: 10.1016/j.jpba.2008.12.013. Epub 2008 Dec 24.

PMID:
19167854
12.

Analysis of pharmaceutical heparins and potential contaminants using (1)H-NMR and PAGE.

Zhang Z, Li B, Suwan J, Zhang F, Wang Z, Liu H, Mulloy B, Linhardt RJ.

J Pharm Sci. 2009 Nov;98(11):4017-26. doi: 10.1002/jps.21729.

PMID:
19642166
13.

Determination of oversulfated chondroitin sulfate and dermatan sulfate impurities in heparin by capillary electrophoresis.

Somsen GW, Tak YH, Toraño JS, Jongen PM, de Jong GJ.

J Chromatogr A. 2009 May 1;1216(18):4107-12. doi: 10.1016/j.chroma.2009.02.063. Epub 2009 Feb 26.

PMID:
19272607
14.

One-dimensional cellulose acetate plate electrophoresis--a feasible method for analysis of dermatan sulfate and other glycosaminoglycan impurities in pharmaceutical heparin.

Domanig R, Jöbstl W, Gruber S, Freudemann T.

J Pharm Biomed Anal. 2009 Jan 15;49(1):151-5. doi: 10.1016/j.jpba.2008.10.017. Epub 2008 Oct 25.

PMID:
19062213
15.

An assessment of polydispersed species in unfractionated and low molecular weight heparins by diffusion ordered nuclear magnetic resonance spectroscopy method.

Bednarek E, Sitkowski J, Bocian W, Mulloy B, Kozerski L.

J Pharm Biomed Anal. 2010 Nov 2;53(3):302-8. doi: 10.1016/j.jpba.2010.03.037. Epub 2010 Apr 2.

PMID:
20417048
16.

Determination of impurities in heparin by capillary electrophoresis using high molarity phosphate buffers.

Wielgos T, Havel K, Ivanova N, Weinberger R.

J Pharm Biomed Anal. 2009 Feb 20;49(2):319-26. doi: 10.1016/j.jpba.2008.11.034. Epub 2008 Dec 3.

PMID:
19155153
17.

Quantitative capillary electrophoresis determination of oversulfated chondroitin sulfate as a contaminant in heparin preparations.

Volpi N, Maccari F, Linhardt RJ.

Anal Biochem. 2009 May 1;388(1):140-5. doi: 10.1016/j.ab.2009.02.012. Epub 2009 Feb 14.

18.

[Capillary electrophoresis analysis of contaminants in heparin sodium for the Japanese pharmacopoeia purity test].

Kakoi N, Kinoshita M, Kawasaki N, Yamaguchi T, Hayakawa T, Kakehi K.

Yakugaku Zasshi. 2009 Oct;129(10):1255-64. Japanese.

19.

Composition of OSCS-contaminated heparin occurring in 2008 in batches on the German market.

Beyer T, Matz M, Brinz D, Rädler O, Wolf B, Norwig J, Baumann K, Alban S, Holzgrabe U.

Eur J Pharm Sci. 2010 Jul 11;40(4):297-304. doi: 10.1016/j.ejps.2010.04.002. Epub 2010 Apr 23.

PMID:
20399266
20.

Establishment of chondroitin B lyase-based analytical methods for sensitive and quantitative detection of dermatan sulfate in heparin.

Wu J, Ji Y, Su N, Li Y, Liu X, Mei X, Zhou Q, Zhang C, Xing XH.

Carbohydr Polym. 2016 Jun 25;144:338-45. doi: 10.1016/j.carbpol.2016.02.074. Epub 2016 Mar 3.

PMID:
27083825

Supplemental Content

Support Center